Fri, February 23, 2024
Thu, February 22, 2024
Wed, February 21, 2024
Tue, February 20, 2024
Mon, February 19, 2024
Fri, February 16, 2024

Stephen Willey Maintained (ABCL) at Strong Buy with Decreased Target to $17 on, Feb 21st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-17-on-feb-21st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Stephen Willey of Stifel, Maintained "AbCellera Biologics Inc." (ABCL) at Strong Buy with Decreased Target from $21 to $17 on, Feb 21st, 2024.

Stephen has made no other calls on ABCL in the last 4 months.



There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Stephen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Stephen


  • Scott Schoenhaus of "Keybanc" Initiated at Buy and Held Target at $6 on, Tuesday, December 5th, 2023

Publication Contributing Sources